Mesoblast Receivables

Mesoblast (MESO) currently reports a receivables of $43M as of December 2025. That compares with $1.7M in the prior-year period — up 2465.2% year over year. Use the charts on this page to explore Mesoblast's receivables history and peer comparisons.

Mesoblast's receivables increased from $1.7M to $43M — a 2465.2% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mesoblast reported $43M in receivables as of December 2025. That compares with $1.7M in the prior-year period — up 2465.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $43M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mesoblast, and consider following MESO for alerts when major investors trade the stock.

Mesoblast is classified in the Healthcare sector. On receivables, it currently shows $43M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MESO with unrelated industries.